{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:37:51Z","timestamp":1765805871306,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.preghy.2017.12.007","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T03:24:22Z","timestamp":1514863462000},"page":"92-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy"],"prefix":"10.1016","volume":"11","author":[{"given":"E.","family":"Shawkat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chmiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.D.","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2017.12.007_b0005","first-page":"105","article-title":"Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy, Pregnancy Hypertens","volume":"4","author":"Magee","year":"2014","journal-title":"An Int. J. Women\u2019s Cardiovasc. Heal."},{"key":"10.1016\/j.preghy.2017.12.007_b0010","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006250-200212000-00037","article-title":"Chronic hypertension in pregnancy","volume":"100","author":"Sibai","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.12.007_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2301","article-title":"Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis","volume":"348","author":"Bramham","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2017.12.007_b0020","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","author":"Abalos","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2017.12.007_b0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1701-2163(16)30592-8","article-title":"Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis","volume":"24","author":"von Dadelszen","year":"2002","journal-title":"J Obs. Gynaecol. Can."},{"key":"10.1016\/j.preghy.2017.12.007_b0030","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1404595","article-title":"Less-tight versus tight control of hypertension in pregnancy","volume":"372","author":"Magee","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.preghy.2017.12.007_b0035","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(82)92202-4","article-title":"Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children","volume":"1","author":"Cockburn","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2017.12.007_b0040","doi-asserted-by":"crossref","first-page":"e005526","DOI":"10.1161\/JAHA.117.005526","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J. Am. Heart Assoc."},{"year":"2010","series-title":"National Institute for Health and Clinical Excellence","author":"National Collaborating Centre for Women\u2019s Health and Children\u2019s","key":"10.1016\/j.preghy.2017.12.007_b0045"},{"key":"10.1016\/j.preghy.2017.12.007_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.preghy.2017.12.007_b0055","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/j.1552-4604.1993.tb01933.x","article-title":"Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis","volume":"33","author":"Saotome","year":"1993","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2017.12.007_b0060","first-page":"CD007449","article-title":"Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension","volume":"8","author":"Wong","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.preghy.2017.12.007_b0065","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2125.2003.02056.x","article-title":"Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension","volume":"57","author":"Minami","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2017.12.007_b0070","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(99)70315-7","article-title":"A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies","author":"Scardo","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2017.12.007_b0075","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(10)60235-8","article-title":"Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis","volume":"375","author":"Webb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2017.12.007_b0080","doi-asserted-by":"crossref","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2017.12.007_b0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.preghy.2017.12.007_b0090","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0753-3322(05)80015-0","article-title":"Circadian rhythm of maternal blood pressure and fetal growth","volume":"59","author":"Maggioni","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.preghy.2017.12.007_b0095","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/1471-0528.12678","article-title":"Beta-Blockers increase the risk of being born small for gestational age or of being institutionalised during infancy","volume":"121","author":"Xie","year":"2014","journal-title":"BJOG An Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2017.12.007_b0100","first-page":"138","article-title":"3 Is BP level achieved related to maternal and perinatal outcomes? A secondary analysis of bp values from the chips (control of hypertension in pregnancy study) randomised controlled trial","volume":"6","author":"Magee","year":"2016","journal-title":"Pregnancy Hypertens An Int. J. Women\u2019s Cardiovasc. Heal."},{"key":"10.1016\/j.preghy.2017.12.007_b0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2017.12.007_b0110","unstructured":"NICE, Hypertension: Clinical management of primary hypertension in adults (NICE clinical guideline 127), NICE (2011) 38."},{"key":"10.1016\/j.preghy.2017.12.007_b0115","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","article-title":"Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials","volume":"336","author":"C. Blood Pressure Lowering Treatment Trialists","year":"2008","journal-title":"Br. Med. J."},{"key":"10.1016\/j.preghy.2017.12.007_b0120","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/HYPERTENSIONAHA.117.09972","article-title":"Labetalol versus nifedipine as antihypertensive treatment for chronic hypertension in pregnancy: a randomized controlled trial","volume":"70","author":"Webster","year":"2017","journal-title":"Hypertension"}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917301320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778917301320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:11Z","timestamp":1761897011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778917301320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":24,"alternative-id":["S2210778917301320"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2017.12.007","relation":{},"ISSN":["2210-7789"],"issn-type":[{"type":"print","value":"2210-7789"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of labetalol and nifedipine MR on blood pressure in women with chronic hypertension in pregnancy","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2017.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}